Eccrine Squamous Syringometaplasia Associated with Pelubiprofen Therapy.
- Author:
Joon Won HUH
1
;
Mingyul JO
;
Jisook YOO
;
Min Soo KIM
;
Kwang Hyun CHOI
;
Hyang Joon PARK
;
Mihn Sook JUE
Author Information
- Publication Type:Case Report
- Keywords: Eccrine squamous syringometaplasia; Metaplasia; Pelubiprofen; Phototoxicity
- MeSH: Dermatitis, Phototoxic; Drug Therapy; Humans; Metaplasia; Skin
- From:Annals of Dermatology 2017;29(3):334-336
- CountryRepublic of Korea
- Language:English
- Abstract: Eccrine squamous syringometaplasia (ESS) is a histologically distinctive skin eruption occurring predominantly in acral or intertriginous areas presenting as erythematous macules, papules or patches. The etiology of ESS remains unclear, but it is usually reported in patients receiving chemotherapy for various malignant neoplasms. To date, only two cases of ESS associated with non-steroidal anti-inflammatory drugs (NSAIDs), which has distinctive clinical features and pathogenesis, have been reported in the literature. Herein, we report a rare and interesting case of ESS associated with pelubiprofen, a recently developed NSAID, which appeared after pelubiprofen therapy and resolved spontaneously after discontinuing the medication.
